Lopurin and Conjunctival disorder - a phase IV clinical study of FDA data

Summary:

Conjunctival disorder is reported as a side effect among people who take Lopurin (allopurinol), especially for people who are female, 60+ old, also take Lasix, and have Hyperuricaemia.

The phase IV clinical study analyzes which people have Conjunctival disorder when taking Lopurin. It is created by eHealthMe based on reports of 188,140 people who have side effects when taking Lopurin from the FDA, and is updated regularly.

What is Lopurin?

Lopurin has active ingredients of allopurinol. It is often used in gout. eHealthMe is studying from 190,798 Lopurin users. Check the latest studies of Lopurin.

What is Conjunctival disorder?

Conjunctival disorder (conjunctival disease) is found to be associated with 63 drugs and 217 conditions by eHealthMe. Check the latest studies of Conjunctival disorder.

On Jul, 13, 2026

188,140 people reported to have side effects when taking Lopurin.
Among them, 12 people (0.01%) have Conjunctival disorder.

Could Lopurin cause Conjunctival disorder?

Among these 12 people:

What is the gender of people who have Conjunctival disorder when taking Lopurin? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Conjunctival disorder when taking Lopurin? *

What are other drugs people take besides Lopurin? *

What are other side effects people have besides Conjunctival disorder? *

Erythema Multiforme (a type of hypersensitivity reaction): 6 people, 50.00%
Itching: 3 people, 25.00%
Blood Urea Increased: 3 people, 25.00%
Rashes (redness): 3 people, 25.00%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 3 people, 25.00%
Mouth Ulcers: 2 people, 16.67%
Serum Ferritin Increased: 2 people, 16.67%
Pain: 2 people, 16.67%
Hepatic Failure (liver failure): 2 people, 16.67%
Lip Ulceration (ulcer of lip): 2 people, 16.67%

What are the existing conditions these people have? *

Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 16.67%
Urinary Tract Infection: 1 person, 8.33%
Sinusitis (inflammation of sinus): 1 person, 8.33%
Sinus Disorder (disease of sinus): 1 person, 8.33%
Respiratory Disorder (respiratory disease): 1 person, 8.33%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
Pain: 1 person, 8.33%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lopurin and have Conjunctival disorder?

- Check whether Conjunctival disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lopurin:

Lopurin (190,798 reports)

Browse all side effects of Lopurin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctival disorder:

Conjunctival disorder (63 drugs)

Browse all the conditions that are associated with Conjunctival disorder:

Conjunctival disorder (217 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on allopurinol (the active ingredients of Lopurin) and Lopurin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.